Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
K-Ras-IN-1
Cat. No.:
OB0225LY-0053
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
K-Ras-IN-1 is a small molecule that selectively inhibits K-Ras mutant proteins.
Synonym:
84783-01-7; K-Ras-IN-1; (2-Hydroxyphenyl)(Pyrrolidin-1-yl)methanethione; (2-Hydroxy-phenyl)-pyrrolidin-1-yl-methanethione
CAS No.:
84783-01-7
Compound CID:
551134
Formula:
C11H13NOS
Formula Weight:
207.29
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
K-Ras-IN-1 can be used for cancer-related drug development, especially for K-Ras-dependent tumors.
Library Information
Targets:
GTPase superfamily
Receptors:
K-Ras; Ras
Pathways:
GPCR/G protein; MAPK
Plate Number:
AOCL-1
Plate Location:
f5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
28 mg/mL; 135.08 mM
